Literature DB >> 28027946

How serpins transport hormones and regulate their release.

Robin W Carrell1, Randy J Read2.   

Abstract

The adaptation of the serpin framework and its mechanism to perform diverse functions is epitomised in the hormone carriers of the blood. Thyroxine and the corticosteroids are transported bound in a 1:1 ratio on almost identical sites in the two homologous binding-globulins, TBG and CBG. Recent structural findings show an equilibrated, rather than on-and-off, release of the hormones from the carriers, reflecting small reversible movements of the hinge region of the reactive loop that modify the conformational flexibility of the underlying hormone-binding site. Consequently, contrary to previous concepts, the binding affinities of TBG and CBG are not fixed but can be allosterically modified to allow differential hormone delivery. Notably, the two carriers function like protein thermocouples with a surge in hormone release as body temperatures rise in fevers, and conversely a large diminution in free hormone levels at hibernation temperatures. By comparison angiotensinogen, the source of the angiotensin peptides that control blood pressure, does not appear to utilise the serpin mechanism. It has instead evolved a 63 residue terminal extension containing the buried angiotensin cleavage site, which on interaction moves into the active cleft of the renin. The conformational shift involved is critically linked by a labile disulphide bridge. The observation of changes in the redox status of this S-S bridge, in the hypertensive complication of pregnancy, pre-eclampsia, has opened an unexpected level of regulation at what is the initial stage in the control of blood pressure.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Angiotensin; Angiotensinogen; CBG; Cortisol; TBG; Thyroxine

Mesh:

Substances:

Year:  2016        PMID: 28027946     DOI: 10.1016/j.semcdb.2016.12.007

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  7 in total

Review 1.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

Review 2.  Protease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction.

Authors:  Jindřich Chmelař; Jan Kotál; Helena Langhansová; Michail Kotsyfakis
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

3.  Molecular basis of a redox switch: molecular dynamics simulations and surface plasmon resonance provide insight into reduced and oxidised angiotensinogen.

Authors:  Jennifer M Crowther; Letitia H Gilmour; Benjamin T Porebski; Sarah G Heath; Neil R Pattinson; Maurice C Owen; Rayleen Fredericks; Ashley M Buckle; Conan J Fee; Christoph Göbl; Renwick C J Dobson
Journal:  Biochem J       Date:  2021-09-17       Impact factor: 3.857

4.  Trade-offs between sperm viability and immune protein expression in honey bee queens (Apis mellifera).

Authors:  Alison McAfee; Abigail Chapman; Jeffery S Pettis; Leonard J Foster; David R Tarpy
Journal:  Commun Biol       Date:  2021-01-08

Review 5.  Angiotensinogen and the Modulation of Blood Pressure.

Authors:  Zimei Shu; Jiahui Wan; Randy J Read; Robin W Carrell; Aiwu Zhou
Journal:  Front Cardiovasc Med       Date:  2021-03-18

6.  Human PZP and common marmoset A2ML1 as pregnancy related proteins.

Authors:  Hirofumi Kashiwagi; Hitoshi Ishimoto; Sun-Ichiro Izumi; Toshiro Seki; Rihito Kinami; Asako Otomo; Kazumi Takahashi; Fuyuki Kametani; Noriaki Hirayama; Erika Sasaki; Takashi Shiina; Kou Sakabe; Mikio Mikami; Yoshie Kametani
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

Review 7.  Insulin-like growth factors: Ligands, binding proteins, and receptors.

Authors:  Derek LeRoith; Jeff M P Holly; Briony E Forbes
Journal:  Mol Metab       Date:  2021-05-04       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.